Dentium Co., Ltd. stock analysis
Want to see KR:145720 full AI Analyst Report?
Dentium Co., Ltd. (145720) Stock Price & Analysis
145720 Stock Chart & Stats
- Day’s Range
- KRW 38,600.00 - KRW 40,650.00
- 52-Week Range
- KRW 35,000.00 - KRW 57,300.00
- Previous Close
- KRW 38,850.00
- Volume
- N/A
- Average Volume (3M)
- 33.54K
- Market Cap
- KRW 340.64B
- Enterprise Value
- KRW 532.72B
- Total Cash (Recent Filing)
- KRW 75.93B
- Total Debt (Recent Filing)
- KRW 300.44B
- Price to Earnings (P/E)
- 18.1
- Beta
- 0.10
- Next Earnings
- Mar 03, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Mar 20, 2026
- Dividend Yield
- 1.52%
Bulls Say, Bears Say
Bulls Say
Healthy Operating Margins
Strong gross, operating, and EBITDA margins indicate that Dentium retains meaningful economics in its dental-device operations. This profitability buffer can support ongoing investment, help absorb cost pressure, and provide resilience over the next several quarters if revenue growth remains uneven.
Moderate Leverage
Moderate and improving leverage gives Dentium a more manageable balance-sheet structure than in earlier periods. Lower debt relative to equity can reduce financial strain, preserve borrowing capacity, and provide greater flexibility to fund operations or strategic investment through changing conditions.
Focused Dental-Device Position
A focused position in implant dentistry gives Dentium a clearly defined medical-device business model serving dental clinics and laboratories. Concentration in a specialized product area can support accumulated expertise, coherent product development, and durable customer relevance within dental care.
Bears Say
Profitability Deterioration
The sharp decline in net margin and return on equity shows that recent revenue is converting into substantially less profit and shareholder return. If this deterioration persists, it could weaken internal reinvestment capacity and reduce the earnings power of an otherwise profitable operating model.
Negative Free Cash Flow
Negative free cash flow, following another negative year, indicates that recent cash conversion is not keeping pace with reported earnings. This can reduce near-term financial flexibility, increase reliance on balance-sheet resources, and constrain Dentium’s ability to fund growth while maintaining shareholder distributions.
Governance And Control Tensions
The court action seeking access to accounting records signals governance or management-control tensions that could distract leadership and increase oversight costs. Ongoing litigation may also complicate investor confidence and capital-allocation decisions until the dispute and its implications become clearer.
Dentium Co., Ltd. News
145720 FAQ
What was Dentium Co., Ltd.’s price range in the past 12 months?
What is Dentium Co., Ltd.’s market cap?
When is Dentium Co., Ltd.’s upcoming earnings report date?
How were Dentium Co., Ltd.’s earnings last quarter?
Is Dentium Co., Ltd. overvalued?
Does Dentium Co., Ltd. pay dividends?
What is Dentium Co., Ltd.’s EPS estimate?
How many shares outstanding does Dentium Co., Ltd. have?
What happened to Dentium Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Dentium Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Dentium Co., Ltd.
Dentium Co., Ltd., based in Seoul, South Korea, is a prominent global manufacturer and supplier of cutting-edge dental implant solutions. The company's extensive product range encompasses various dental implant systems, such as Superline, Implantium, Simpleline II, Slimline, Overdenture System, NR Line, and Implantium II. Dentium also develops a comprehensive assortment of surgical instruments, offering specialized kits for procedures like sinus lifts, osteotomy, and restoration, alongside individual tools such as harvest drills, surgical guides, and GBR systems. Additionally, they provide essential regenerative products like bone grafts, membranes, and tissue regeneration materials. Their portfolio is further enhanced by digital dentistry tools, laboratory supplies, iCT motors, and injections. Founded in 2000, the company initially operated as Biostech Co., Ltd. before adopting its current name, Dentium Co., Ltd., in August 2002.
- Sector
- General
- Industry
- Medical - Instruments & Supplies
- Employees
- 876
- Website
- www.dentium.co.kr
- Address
- KR
Dentium Co., Ltd. (145720) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 5 | 4 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 9 | 0 | 3 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| KR:042520Hans Biomed Corp |


